Hemofarm A.D. is a Serbian-based company that specializes in the research, development, manufacture, sale, and export of generic pharmaceutical products. Established in 1960, their product range includes prescription drugs tailored to address cardiovascular diseases, antibiotics, and neuropsychiatric conditions. Additionally, the company offers over-the-counter drugs, dietary supplements, and enzyme-based products such as magnetrons for energy exchange, bone structure support, electrolyte balance, and nervous system function. Hemofarm has carved a niche within the Manufacturing and Pharmaceutical industries. Currently, there is no available information regarding their last investment and the involved investors.
There is no investment information
No recent news or press coverage available for Hemofarm A.D..
We care about your data, and we'd love to use cookies make your experience better.